Skip to main content
OCLN
OTC Technology

OriginClear Faces Going Concern Doubt Amid CEO Death, Massive Dilution, and Internal Control Weaknesses

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.001
Mkt Cap
$14.758M
52W Low
$0.001
52W High
$0.003
Market data snapshot near publication time

summarizeSummary

OriginClear's 2025 annual report reveals substantial doubt about its ability to continue as a going concern, a significant increase in outstanding shares, ineffective internal controls, and the recent passing of its CEO, T. Riggs Eckelberry.


check_boxKey Events

  • Going Concern Warning

    Auditors expressed "substantial doubt" about the company's ability to continue operations due to recurring losses and limited cash resources.

  • CEO Passes Away

    Founder and CEO T. Riggs Eckelberry passed away on April 9, 2026, leading to the appointment of Cory Mertes as interim CEO and CFO.

  • Massive Share Dilution

    Outstanding common shares surged from 1.67 billion in 2024 to over 15.6 billion in 2025, representing an 834% increase. If all authorized common shares were issued, dilution would be 92.02%.

  • Ineffective Internal Controls

    Management concluded that disclosure controls and procedures were ineffective as of December 31, 2025, due to a lack of segregation of duties from a small staff size.


auto_awesomeAnalysis

The 2025 10-K filing for OriginClear, Inc. paints a highly concerning picture of the company's financial health and operational stability. The auditors have expressed "substantial doubt about its ability to continue as a going concern," a critical red flag for investors. This is compounded by a massive 834% increase in outstanding common shares, from 1.67 billion in 2024 to over 15.6 billion in 2025, indicating severe dilution. Furthermore, the company's management has declared its disclosure controls and procedures ineffective due to a small staff size, raising significant concerns about financial reporting reliability. The recent passing of CEO T. Riggs Eckelberry on April 9, 2026, and the appointment of an interim successor adds further uncertainty to leadership. While revenue increased and net loss decreased, these improvements are overshadowed by the fundamental challenges of financial viability, governance, and operational risk. The termination of a planned SPAC merger for its subsidiary WODI in late 2024 also highlights past strategic setbacks. Investors should be aware of the extreme risks associated with this company's ability to sustain operations.

At the time of this filing, OCLN was trading at $0.00 on OTC in the Technology sector, with a market capitalization of approximately $14.8M. The 52-week trading range was $0.00 to $0.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed OCLN - Latest Insights

OCLN
Apr 13, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
8
OCLN
Apr 10, 2026, 6:15 PM EDT
Filing Type: 10-K
Importance Score:
9